We foster a culture of collaboration, continuous learning, and accountability, enabling our team to deliver excellence in every function.
Symyza Biotech is a rapidly growing pharmaceutical company committed to improving health outcomes through the development, manufacturing, and distribution of high-quality medicinal products. Headquartered in Bhubaneswar, Odisha, we operate with a clear mission: to deliver safe, effective, and affordable healthcare solutions that enhance the quality of life for people across diverse communities.
Founded with a vision to bridge the gap between quality and affordability in the pharmaceutical sector, Symyza Biotech has established itself as a trusted name in the formulation and production of a wide range of dosage forms. Our product portfolio includes tablets, capsules, ointments, and other pharmaceutical preparations designed to meet the evolving needs of healthcare providers and patients alike.
Our registered office is located at:
Karnatak:
Plot No. 37-A2, Khatha No. 119137-A2,
Hosakote Industrial Area, Chokkahally village,
KasabaHobli, Hosakote Taluk, Bangalore, Karnatak.
Odisha:
HIG 2/318, Satya Sai Enclaves
Kolathia HB, Khandagiri
Bhubaneswar – 751030, Odisha, India
This strategic location enables us to efficiently manage operations, maintain strong distribution networks, and serve clients across multiple regions.
To become a globally recognized pharmaceutical company known for innovation, quality, and accessibility, while contributing meaningfully to the advancement of healthcare standards.
Our mission is centered on three core pillars:
At Symyza Biotech, our operations and decisions are guided by a strong set of values:
Symyza Biotech specializes in the manufacturing of a diverse range of pharmaceutical dosage forms:
We produce a wide variety of tablets formulated for different therapeutic categories. Our tablet manufacturing processes ensure uniformity, stability, and bioavailability, meeting stringent quality standards.
Our capsule formulations are designed for precision dosing and optimal patient compliance. We focus on maintaining consistency in fill weight, dissolution profiles, and overall product integrity.
We manufacture ointments and other topical preparations aimed at providing effective relief for dermatological and localized conditions. These products are developed with careful consideration of skin compatibility and therapeutic effectiveness.
In addition to tablets, capsules, and ointments, we are equipped to handle the production of various other pharmaceutical formulations, catering to evolving market demands and therapeutic advancements.
Our manufacturing philosophy is rooted in quality assurance and compliance with regulatory standards. We follow Good Manufacturing Practices (GMP) to ensure that every product leaving our facility is safe, effective, and reliable.
Key aspects of our manufacturing capabilities include:
We invest in modern equipment and technologies to enhance efficiency and maintain consistency across batches. Every stage of production, from raw material procurement to final packaging, undergoes rigorous quality checks.
Quality is at the heart of everything we do. Our Quality Assurance (QA) and Quality Control (QC) teams work diligently to ensure that all products comply with regulatory requirements and industry standards.
Our quality systems include:
We believe that maintaining strict quality standards not only builds trust but also safeguards patient health.
Innovation drives our growth. Our Research and Development (R&D) team is dedicated to creating improved formulations and exploring new therapeutic possibilities.
We focus on:
By investing in R&D, Symyza Biotech aims to stay ahead in a competitive pharmaceutical landscape and contribute to medical advancements.
Our strength lies in our people. Symyza Biotech is powered by a team of experienced professionals, including pharmacists, scientists, quality experts, and management personnel who bring deep industry knowledge and expertise.
We foster a culture of collaboration, continuous learning, and accountability, enabling our team to deliver excellence in every function.
Symyza Biotech is steadily expanding its footprint in the pharmaceutical market. Through strong partnerships with distributors, healthcare institutions, and medical professionals, we ensure that our products reach those who need them most.
Our distribution network is designed to be efficient, reliable, and responsive, allowing us to meet demand across different regions with consistency.
We adhere strictly to national and international regulatory guidelines. Our processes are aligned with industry standards to ensure product safety and reliability.
Compliance is not just a requirement for us—it is a responsibility. We continuously update our systems and practices to remain aligned with evolving regulations.
As a responsible pharmaceutical company, we are committed to minimizing our environmental impact. We adopt sustainable practices in manufacturing, waste management, and resource utilization.
We also believe in contributing to society through ethical business practices and by supporting initiatives that promote public health and well-being.
Looking ahead, Symyza Biotech aims to:
Our journey is driven by a commitment to excellence and a passion for making a difference in people’s lives.
Symyza Biotech stands as a symbol of trust, quality, and innovation in the pharmaceutical industry. With a strong foundation, dedicated team, and forward-looking approach, we continue to grow and evolve to meet the healthcare challenges of today and tomorrow.
We remain steadfast in our mission to deliver high-quality medicines that improve lives—because at Symyza Biotech, your health is our priority.

Innovative research-driven approach to discover and develop effective pharmaceutical solutions, ensuring safety, quality, and therapeutic value at every stage.

Strict adherence to global regulatory standards with comprehensive quality checks to ensure consistency, reliability, and patient safety.

Advanced manufacturing processes with state-of-the-art technology to produce high-quality medicines efficiently and at scale.

Robust distribution network combined with a patient-centric approach to ensure timely delivery and improved healthcare outcomes.